Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass balance and pharmacokinetics study of [14C]-S 47445 in healthy male volunteers
NL-OMON35510Phase 1Active, not recruiting
- Sponsor
- Servier
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of tulrampator in Alzheimer's disease (AD), sponsored by Servier. Primary endpoints: Excretion balance of total radioactivity, Pharmacokinetics of total radioactivity and 2 more. Started Nov 2011; status: active, not recruiting.
02
Drugs
tulrampator
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NL-OMON35510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35510.